Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk

Clinical trial NCT05369585 · COMPLETED

Trial details

NCT number: NCT05369585
Sponsor: Valbiotis
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Prediabetic State Dysglycemia Overweight and Obesity

Start date: 2022-04-25
Primary completion: 2023-04-12
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.